Coherus Oncology, Inc. Stock-Based Compensation
Coherus Oncology, Inc. (CHRS) reported Stock-Based Compensation of $4.97 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-05
- Coherus Oncology, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $2.58M, a 52.35% decline year-over-year.
- Coherus Oncology, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $2.38M, a 55.60% decline year-over-year.
- Coherus Oncology, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $2.78M, a 56.39% decline year-over-year.
- Coherus Oncology, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $3.39M, a 50.66% decline year-over-year.
- Coherus Oncology, Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $16.97M, a 38.98% decline from fiscal 2024.
- Coherus Oncology, Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $27.80M.
- Coherus Oncology, Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $50.74M, a 1.22% decline from fiscal 2021.
- Coherus Oncology, Inc. share-based payment arrangement, noncash expense for fiscal 2021 was $51.36M, a 34.60% increase from fiscal 2020.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $4.97M 10-Q · filed 2026-08-05 | $7.75M derived: sum of 3 quarters · filed 2026-08-05 | $11.14M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $2.38M 10-Q · filed 2026-05-11 | $5.17M derived: sum of 2 quarters · filed 2026-05-11 | $8.56M derived: sum of 3 quarters · filed 2026-05-11 | $13.98M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $2.78M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $6.17M derived: sum of 2 quarters · filed 2026-03-09 | $11.59M derived: sum of 3 quarters · filed 2026-08-05 | $16.97M 10-K · filed 2026-03-09 |
| 2025-09-30 | $3.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $8.81M derived: sum of 2 quarters · filed 2026-08-05 | $14.18M 10-Q · filed 2025-11-06 | $20.57M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $5.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $10.79M 10-Q · filed 2026-08-05 | $17.18M derived: sum of 3 quarters · filed 2026-08-05 | $24.05M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $5.37M 10-Q · filed 2026-05-11 | $11.76M derived: sum of 2 quarters · filed 2026-05-11 | $18.62M derived: sum of 3 quarters · filed 2026-05-11 | $25.86M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $6.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $13.25M derived: sum of 2 quarters · filed 2026-03-09 | $20.48M derived: sum of 3 quarters · filed 2026-03-09 | $27.80M 10-K · filed 2026-03-09 |
| 2024-09-30 | $6.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $14.10M derived: sum of 2 quarters · filed 2025-11-06 | $21.42M 10-Q · filed 2025-11-06 | $32.22M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $7.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $14.55M 10-Q · filed 2025-08-07 | $25.35M derived: sum of 3 quarters · filed 2025-11-13 | $35.30M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-03-31 | $7.32M 10-Q · filed 2025-05-12 | $18.12M derived: sum of 2 quarters · filed 2025-11-13 | $28.07M derived: sum of 3 quarters · filed 2025-11-13 | $38.15M derived: sum of 4 quarters · filed 2025-11-13 |
| 2023-12-31 | $10.80M derived: 8-K 12 month − 10-Q 9 month · filed 2025-11-13 | $20.75M derived: sum of 2 quarters · filed 2025-11-13 | $30.83M derived: sum of 3 quarters · filed 2025-11-13 | $43.11M 8-K · filed 2025-11-13 |
| 2023-09-30 | $9.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $20.03M derived: sum of 2 quarters · filed 2024-11-06 | $32.31M 10-Q · filed 2024-11-06 | $44.04M derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-06-30 | $10.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $22.36M 10-Q · filed 2024-08-08 | $34.09M derived: sum of 3 quarters · filed 2025-03-17 | $46.37M derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-03-31 | $12.28M 10-Q · filed 2024-05-09 | $24.01M derived: sum of 2 quarters · filed 2025-03-17 | $36.29M derived: sum of 3 quarters · filed 2025-03-17 | $50.14M derived: sum of 4 quarters · filed 2025-03-17 |
| 2022-12-31 | $11.73M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $24.01M derived: sum of 2 quarters · filed 2025-03-17 | $37.86M derived: sum of 3 quarters · filed 2025-03-17 | $50.74M 10-K · filed 2025-03-17 |
| 2022-09-30 | $12.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $26.13M derived: sum of 2 quarters · filed 2023-11-06 | $39.01M 10-Q · filed 2023-11-06 | $49.96M derived: sum of 4 quarters · filed 2024-03-15 |
| 2022-06-30 | $13.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $26.73M 10-Q · filed 2023-08-02 | $37.67M derived: sum of 3 quarters · filed 2024-03-15 | $49.61M derived: sum of 4 quarters · filed 2024-03-15 |
| 2022-03-31 | $12.88M 10-Q · filed 2023-05-08 | $23.82M derived: sum of 2 quarters · filed 2024-03-15 | $35.76M derived: sum of 3 quarters · filed 2024-03-15 | $47.36M derived: sum of 4 quarters · filed 2024-03-15 |
| 2021-12-31 | $10.95M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $22.89M derived: sum of 2 quarters · filed 2024-03-15 | $34.48M derived: sum of 3 quarters · filed 2024-03-15 | $51.36M 10-K · filed 2024-03-15 |
| 2021-09-30 | $11.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $23.53M derived: sum of 2 quarters · filed 2022-11-08 | $40.42M 10-Q · filed 2022-11-08 | $50.29M derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-06-30 | $11.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $28.48M 10-Q · filed 2022-08-04 | $38.35M derived: sum of 3 quarters · filed 2023-03-06 | $47.66M derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-03-31 | $16.88M 10-Q · filed 2022-05-05 | $26.76M derived: sum of 2 quarters · filed 2023-03-06 | $36.06M derived: sum of 3 quarters · filed 2023-03-06 | $45.49M derived: sum of 4 quarters · filed 2023-03-06 |
| 2020-12-31 | $9.87M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $19.18M derived: sum of 2 quarters · filed 2023-03-06 | $28.61M derived: sum of 3 quarters · filed 2023-03-06 | $38.16M 10-K · filed 2023-03-06 |
| 2020-09-30 | $9.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $18.73M derived: sum of 2 quarters · filed 2021-11-08 | $28.29M 10-Q · filed 2021-11-08 | $35.56M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-06-30 | $9.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $18.98M 10-Q · filed 2021-08-05 | $26.25M derived: sum of 3 quarters · filed 2022-02-23 | $35.09M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-03-31 | $9.55M 10-Q · filed 2021-05-06 | $16.83M derived: sum of 2 quarters · filed 2022-02-23 | $25.66M derived: sum of 3 quarters · filed 2022-02-23 | $33.65M derived: sum of 4 quarters · filed 2022-02-23 |
| 2019-12-31 | $7.27M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $16.11M derived: sum of 2 quarters · filed 2022-02-23 | $24.10M derived: sum of 3 quarters · filed 2022-02-23 | $33.59M 10-K · filed 2022-02-23 |
| 2019-09-30 | $8.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $16.82M derived: sum of 2 quarters · filed 2020-11-05 | $26.32M 10-Q · filed 2020-11-05 | $35.15M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $7.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $17.49M 10-Q · filed 2020-08-06 | $26.31M derived: sum of 3 quarters · filed 2021-02-25 | $34.87M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $9.49M 10-Q · filed 2020-05-07 | $18.32M derived: sum of 2 quarters · filed 2021-02-25 | $26.88M derived: sum of 3 quarters · filed 2021-02-25 | $35.57M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $8.83M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $17.39M derived: sum of 2 quarters · filed 2021-02-25 | $26.08M derived: sum of 3 quarters · filed 2021-02-25 | $34.80M 10-K · filed 2021-02-25 |
| 2018-09-30 | $8.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $17.25M derived: sum of 2 quarters · filed 2019-11-08 | $25.97M 10-Q · filed 2019-11-08 | $34.30M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | $8.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | $17.41M 10-Q · filed 2019-08-05 | $25.74M derived: sum of 3 quarters · filed 2020-02-27 | $33.92M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | $8.72M 10-Q · filed 2019-05-09 | $17.05M derived: sum of 2 quarters · filed 2020-02-27 | $25.23M derived: sum of 3 quarters · filed 2020-02-27 | $34.31M derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | $8.33M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $16.52M derived: sum of 2 quarters · filed 2020-02-27 | $25.59M derived: sum of 3 quarters · filed 2020-02-27 | $33.40M 10-K · filed 2020-02-27 |
| 2017-09-30 | $8.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $17.25M derived: sum of 2 quarters · filed 2018-11-08 | $25.07M 10-Q · filed 2018-11-08 | $32.75M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | $9.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $16.88M 10-Q · filed 2018-08-08 | $24.57M derived: sum of 3 quarters · filed 2019-02-28 | $32.84M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | $7.81M 10-Q · filed 2018-05-10 | $15.49M derived: sum of 2 quarters · filed 2019-02-28 | $23.77M derived: sum of 3 quarters · filed 2019-02-28 | $29.91M derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | $7.68M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $15.96M derived: sum of 2 quarters · filed 2019-02-28 | $22.10M derived: sum of 3 quarters · filed 2019-02-28 | $27.42M 10-K · filed 2019-02-28 |
| 2016-09-30 | $8.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | $14.42M derived: sum of 2 quarters · filed 2017-11-06 | $19.74M 10-Q · filed 2017-11-06 | $24.91M derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-06-30 | $6.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $11.47M 10-Q · filed 2017-08-07 | $16.64M derived: sum of 3 quarters · filed 2018-03-08 | $21.38M derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-03-31 | $5.32M 10-Q · filed 2017-05-08 | $10.49M derived: sum of 2 quarters · filed 2018-03-08 | $15.24M derived: sum of 3 quarters · filed 2018-03-08 | $19.86M derived: sum of 4 quarters · filed 2018-03-08 |
| 2015-12-31 | $5.17M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $9.92M derived: sum of 2 quarters · filed 2018-03-08 | $14.54M derived: sum of 3 quarters · filed 2018-03-08 | $16.72M 10-K · filed 2018-03-08 |
| 2015-09-30 | $4.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $9.37M derived: sum of 2 quarters · filed 2016-11-09 | $11.55M 10-Q · filed 2016-11-09 | $15.37M derived: sum of 4 quarters · filed 2017-03-14 |
| 2015-06-30 | $4.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $6.80M 10-Q · filed 2016-08-09 | $10.63M derived: sum of 3 quarters · filed 2017-03-14 | $13.36M derived: sum of 4 quarters · filed 2017-03-14 |
| 2015-03-31 | $2.18M 10-Q · filed 2016-05-09 | $6.01M derived: sum of 2 quarters · filed 2017-03-14 | $8.74M derived: sum of 3 quarters · filed 2017-03-14 | $9.95M derived: sum of 4 quarters · filed 2017-03-14 |
| 2014-12-31 | $3.83M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | $6.56M derived: sum of 2 quarters · filed 2017-03-14 | $7.77M derived: sum of 3 quarters · filed 2017-03-14 | $11.06M 10-K · filed 2017-03-14 |
| 2014-09-30 | $2.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | $3.94M derived: sum of 2 quarters · filed 2015-11-10 | $7.24M 10-Q · filed 2015-11-10 | $7.55M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | $1.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $4.50M 10-Q · filed 2015-08-10 | $4.81M derived: sum of 3 quarters · filed 2016-02-29 | |
| 2014-03-31 | $3.29M 10-Q · filed 2015-05-11 | $3.60M derived: sum of 2 quarters · filed 2016-02-29 | ||
| 2013-12-31 | $311.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $2.04M 10-K · filed 2016-02-29 | ||
| 2013-09-30 | $1.73M 10-Q · filed 2014-12-15 | |||
| 2012-12-31 | $443.00K 10-K · filed 2015-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |